U.S. DOD/CDMRP: Peer Reviewed Medical Research Program (PRMRP) – COVID-19 (for Emerging Viral Diseases and Respiratory Health– Pre-proposals

Topics of interest: Arthritis • Burn Pit Exposure • Cardiomyopathy • Congenital Heart Disease • Diabetes • Dystonia • Eating Disorders • Emerging Viral Diseases • Endometriosis • Epidermolysis Bullosa • Familial Hypercholesterolemia • Fibrous Dysplasia • Focal Segmental Glomerulosclerosis • Food Allergies • Fragile X • Frontotemporal Degeneration • Hemorrhage Control • Hepatitis B • Hydrocephalus • Hypertension • Inflammatory Bowel Diseases • Malaria • Metals Toxicology • Mitochondrial Disease • Myalgic Encephalomyelitis/Chronic Fatigue Syndrome • Myotonic Dystrophy • Non-Opioid Therapy for Pain Management • Nutrition Optimization • Pathogen-Inactivated Blood Products • Peripheral Neuropathy • Plant-Based Vaccines • Platelet-Like Cell Production • Polycystic Kidney Disease • Pressure Ulcers • Pulmonary Fibrosis • Respiratory Health • Rheumatoid Arthritis • Sleep Disorders and Restriction • Suicide Prevention • Sustained Release Drug Delivery • Vascular Malformations • Women’s Heart Disease

28.4 | Investigator-Initiated Research Award: $1.6M/ $2M Partnering PI Option. Maximum period of performance is 4 years

28.4 | Technology/Therapeutic Development Award: Funding Level 1- $2M for 4 years. Funding Level 2- $4M for 4 years.

29.4 | *Discovery Award - Supports innovative, high-risk research that will provide new insights, paradigms, technologies, or applications. Funding: up to $200K for 2 years.

https://ebrap.org/eBRAP/public/Program.htm